CatalystWireBeta

Presentation at 43rd Annual J.P. Morgan Conference

In brief · summary, not quotable

No summary for this filing – the full text is below.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your ONT notes

Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore"), the company delivering a new generation of nanopore-based molecular sensing technology, will participate in the 43rd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel, San Francisco, California, USA.

Gordon Sanghera, Chief Executive Officer, will present on Monday, 13 January 2025 at 11:15 - 11:55am PST / 7:15 - 7:55pm GMT. The 40-minute session will include a presentation and a moderated Q&A discussion.

A live webcast of the presentation and Q&A session can be accessed via the Investor Relations section of Oxford Nanopore's website at: https://nanoporetech.com/about-us/investors/reports. A replay will be available for at least 30 days following the event via the same link.

[ENDS]

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note